The role of prophylaxis in bleeding disorders

Area of Science:

• Hematology
• Bleeding Disorders
• Clinical Research

Background:

• Severe von Willebrand's disease (VWD) can cause significant bleeding complications and chronic morbidity.
• Experience with prophylactic treatment in severe VWD is limited, necessitating further investigation.
• The von Willebrand's Disease Prophylaxis Network (VWD PN) was established to address this knowledge gap.

Purpose of the Study:

• To investigate the efficacy and safety of prophylactic treatment in severe forms of von Willebrand's disease.
• To establish evidence-based guidelines for VWD prophylaxis.
• To compare prophylactic treatment with on-demand treatment in VWD patients.

Main Methods:

• Establishment of the international VWD Prophylaxis Network (VWD PN) in 2006.
• Recruitment of patients from 18 European and North American centers, with an additional 40 centers preparing to join.
• Conducting retrospective and prospective studies to evaluate prophylaxis in VWD.

Main Results:

• Prophylaxis in VWD aims to prevent mucosal and joint bleeds, reducing chronic morbidity.
• Guidelines for prophylaxis in rare bleeding disorders remain controversial due to a lack of randomized studies.
• Prophylactic treatment is considered superior to on-demand treatment in hemophilia, with benefits observed in joint health and quality of life.

Conclusions:

• Long-term prophylaxis is indicated for severe VWD, but requires careful management in specialized centers.
• The benefits of prophylaxis must be weighed against potential side effects.
• Optimal prophylactic strategies, including early initiation (primary prophylaxis), dose, and interval, need further definition based on individual patient needs and healthcare resources.